Listen: Gilead’s growing pains, Covid’s origins, & Theranos as prestige TV

Can biotech companies age gracefully? Where did Covid-19 come from? And does Theranos make for good television?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We examine Gilead Sciences’ recent struggles and what the company’s predicament says about the drug industry. Then, MIT Technology Review reporter Antonio Regalado joins us to discuss his new podcast investigating the origins of Covid-19. We also discuss the latest Theranos trial, playing Elizabeth Holmes on TV, and how we managed to make 200 episodes of this show.

For more on what we cover, here’s the latest on Gilead; here’s the “Curious Coincidence” podcast; here’s where you can subscribe to the First Opinion Podcast; and here’s our complete coverage of the Covid-19 pandemic.

Be sure to sign up on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].